Article
Clinical practice guidelines for the management of adult diffuse gliomas.
Cancer letters - 28 Feb 2021
Jiang Tao, Nam Do-Hyun, Ram Zvi, Poon Wai-Sang, Wang Jiguang, Boldbaatar Damdindorj, Mao Ying, Ma Wenbin, Mao Qing, You Yongping, Jiang Chuanlu, Yang Xuejun, Kang Chunsheng, Qiu Xiaoguang, Li Wenbin, Li Shaowu, Chen Ling, Li Xuejun, Liu Zhixiong, Wang Weimin, Bai Hongmin, Yao Yu, Li Shouwei, Wu Anhua, Sai Ke, Li Guilin, Yao Kun, Wei Xinting, Liu Xianzhi, Zhang Zhiwen, Dai Yiwu, Lv Shengqing, Wang Liang, Lin Zhixiong, Dong Jun, Xu Guozheng, Ma Xiaodong, Zhang Wei, Zhang Chuanbao, Chen Baoshi, You Gan, Wang Yongzhi, Wang Yinyan, Bao Zhaoshi, Yang Pei, Fan Xing, Liu Xing, Zhao Zheng, Wang Zheng, Li Yiming, Wang Zhiliang, Li Guanzhang, Fang Shengyu, Li Lianwang, Liu Yanwei, Liu Shuai, Shan Xia, Liu Yuqing, Chai Ruichao, Hu Huimin, Chen Jing, Yan Wei, Cai Jinquan, Wang Hongjun, Chen Lingchao, Yang Yuan, Wang Yu, Han Lei, Wang Qixue
Abstract excerpt
To follow the revision of the fourth edition of WHO classification and the recent progress on the management of diffuse gliomas, the joint guideline committee of Chinese Glioma Cooperative Group (CGCG), Society for Neuro-Oncology of China (SNO-China) and Chinese Brain Cancer Association (CBCA) updated the clinical practice guideline. It provides recommendations for diagnostic and management decisions, and for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
